Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho Biotech Procrit

Executive Summary

HCFA instructs Medicare carriers that epoetin alfa "be afforded" to five target populations for preoperative use. "It has been reported to us that a number of carriers are currently considering, or already have, implemented noncoverage policies for the preoperative use of Procrit, based upon the premise that this use of Procrit is a preventive service," HCFA said in a recent program memorandum
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS034647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel